Meda AB

Cipla grants global rights to Meda for nasal spray 'Dymista'

Cipla Wednesday said it has granted the global commercialisation rights for its nasal spray 'Dymista' to Swedish partner Meda AB except for certain geographies.

Jun 05, 2013, 20:20 PM IST

Sun Pharma shares fall over talks to buy Sweden's Meda

Sun Pharmaceutical’s share prices fell as much as 2.23 percent on Monday amidst reports that it is in talks to buy Sweden's Meda AB for over $5 billion.

Jun 03, 2013, 12:15 PM IST

Sun in talks to buy Sweden's Meda for up to $5 bn: Reports

Drug major Sun Pharmaceutical Industries is said to be in talks to buy Sweden's pharma firm Meda AB in a deal worth up to USD 5 billion, according to media reports.

Jun 02, 2013, 15:02 PM IST

Sun Pharmaceutical in talks to buy Meda for over $5 bn: Report

The pharma company’s stocks last traded down 2.54% at Rs 1,045.50 for the week ended yesterday.

Jun 01, 2013, 09:08 AM IST